| Dr Joshua L Greenspan, MD | |
|
14 Manchester Square, Suite 290, Portsmouth, NH 03801-7866 | |
| (603) 766-8500 | |
| Not Available |
| Full Name | Dr Joshua L Greenspan |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 30 Years |
| Location | 14 Manchester Square, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962457218 | NPI | - | NPPES |
| 432039999 | Medicaid | ME | |
| 3075123 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 13011 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
| Entity Name | American Pain Institute Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437597697 PECOS PAC ID: 7911140637 Enrollment ID: O20130828000740 |
News Archive
Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered a molecule, or biomarker, called CD61 on the surface of drug-resistant tumors that appears responsible for inducing tumor metastasis by enhancing the stem cell-like properties of cancer cells.
A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults- glioblastoma multiforme. The scientists found that by targeting this biomarker and depleting it with a potential drug, they were able to prevent the progression and relapse of the brain tumour.
Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis.
Flipping a single molecular switch can reverse illness in a model of sickle cell disease, according to a study by researchers at Children's Hospital Boston and Dana-Farber Cancer Institute. When turned off, the switch, a protein called BCL11A, allows the body to manufacture red blood cells with an alternate form of hemoglobin unaffected by the mutation that causes the disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua L Greenspan, MD 14 Manchester Square, Suite 290, Portsmouth, NH 03801 Ph: (603) 766-8500 | Dr Joshua L Greenspan, MD 14 Manchester Square, Suite 290, Portsmouth, NH 03801-7866 Ph: (603) 766-8500 |
News Archive
Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered a molecule, or biomarker, called CD61 on the surface of drug-resistant tumors that appears responsible for inducing tumor metastasis by enhancing the stem cell-like properties of cancer cells.
A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults- glioblastoma multiforme. The scientists found that by targeting this biomarker and depleting it with a potential drug, they were able to prevent the progression and relapse of the brain tumour.
Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis.
Flipping a single molecular switch can reverse illness in a model of sickle cell disease, according to a study by researchers at Children's Hospital Boston and Dana-Farber Cancer Institute. When turned off, the switch, a protein called BCL11A, allows the body to manufacture red blood cells with an alternate form of hemoglobin unaffected by the mutation that causes the disease.
› Verified 5 days ago
Olivera Janjic Quitkin, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 333 Borthwick Ave, Portsmouth Anesthesia Associates, Portsmouth, NH 03801 Phone: 603-436-5110 | |
Michael N Baker, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Griffin Road, Suite B, Portsmouth, NH 03801 Phone: 603-431-8819 Fax: 603-427-2540 | |
Dr. Peter Chiayen Huang, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 333 Borthwick Ave, Portsmouth, NH 03801 Phone: 603-436-5110 | |
Dr. Andrew Joseph Kulesza, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 333 Borthwick Ave, Portsmouth, NH 03801 Phone: 603-436-5110 | |
Dr. Trevor B Emory, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 333 Borthwick Ave, Portsmouth, NH 03801 Phone: 603-436-5110 | |
Dr. Richard James Duffy, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 333 Borthwick Ave, Portsmouth, NH 03801 Phone: 603-436-5110 | |
Dr. Robert Lehn, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 14 Manchester Sq, Portsmouth, NH 03801 Phone: 603-766-8500 Fax: 603-766-8550 |